Macrogenics MGNX Earnings Call Transcripts

NASDAQ MGNX
$2.34 +0.01 (+0.43%)
At close: Nov 9, 2026 · 4:00 PM EST
19 earnings calls on file for Macrogenics, from Q4 2019 to Q4 2024. Each transcript opens in a new tab.
Latest earnings call

Macrogenics Q4 2024 Earnings Call

Mar 20, 2025 4,956 words · 22 min read
  • James KarrelsSenior Vice President, Chief Financial Officer, and Secretary
  • Scott E. KoenigPresident, Chief Executive Officer, and Director
  • Stephen EckSenior Vice President, Clinical Development, and Chief Medical Officer
  • Jim KarrelsSenior Vice President, Chief Financial Officer, and Secretary
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Macrogenics Earnings Call Transcripts

Calls19
LatestMar 20, 2025
SinceQ4 2019

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 19 Macrogenics transcripts Register to get access to Macrogenics’s earnings call transcripts.